CD274 and cancer: Programmed cell death ligand 1 (PD-L1) functions as a pivotal immune checkpoint commonly expressed in multiple types of human cancers, exerting a crucial role in immune evasion by repressing activated T lymphocytes via binding to PD-1 (Yi et al., 2022).